Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Peritoneal Dialysis-associated Peritonitis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Peking University First Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

Peking University First Hospital

Collaborators

Peking University Third Hospital, Peking University People's Hospital

Enrollment target

~176 participants

Started

June 2023

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis — Stella